Menu
No results found.
Weekly Share Price & Valuation Overview
Surgical Science Sweden AB (publ)
Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy training; URO Mentor, a virtual reality simulator for endourology training; EndoSim, a realistic scope simulator; FlexVR, a flexible and portable training platform which is designed to teach basic and advanced skills for robotic surgery; and LAP Mentor provides a wide array of laparoscopic training cases. It also provides LapSim training system comprising LapSim Haptic simulator that provides laparoscopic training; LapSim essence, a portable and ready-to-use VR simulator; and LapSim 360, which provides a high-immersion virtual reality training experience; MentorLearn, an end-to-end educational platform that makes simulation course management; and LapSim ST, a state-of-the-art training system that prepares students for the operating room. In addition, the company offers PELVIC Mentor simulator provides anatomy and pelvic exam training; Perc Mentor suite for image-guided interventions; RobotiX Mentor for practice the motor and cognitive skills for surgeons; Simball Box, which combines with digitally collected metrics into a powerful training tool; Spine Mentor, a training simulator for minimal invasive spine surgery; TEE Express, designed to teach Trans-Esophageal Echocardiography procedure using a TEE probe; TraumaVR, an ultimate mix of manikin and VR simulation; and Ultrasound Mentor for ultrasound training with multiple medical specialties. Surgical Science AB was incorporated in 1997 and is based in Gothenburg, Sweden.
- Growth + profitability: double-digit revenue and profit margins.
- Healthy operating margin (≥15%) indicates efficient core operations.
- High gross margin (≥35%) suggests strong pricing power or cost control.
- Double-digit profit margin (≥10%) supports robust bottom-line economics.
- Revenue growth ≥10% indicates solid top-line momentum.
- Earnings growth ≥10% supports improving profitability trajectory.
- Quick ratio ≥1.0 indicates obligations can be met without inventory.
- Net cash balance sheet provides flexibility for downturns and investment.
- Market Cap Total equity value of the company (share price × shares outstanding).
- SEK 5.02B
- Enterprise Value Operating value: market cap + total debt − cash.
- SEK 4.41B
- Total Revenue (TTM) Sales over the last twelve months. May be estimated from revenue per share when inconsistent.
- SEK 946.53M
- Gross Profit (TTM) Revenue minus cost of goods sold over the last twelve months. Hidden for financial institutions or if redundant.
- SEK 647.17M
- EBITDA (TTM) Earnings before interest, taxes, depreciation and amortization (TTM). Hidden for financials or if implausible.
- SEK 196.16M
- Revenue per Share (TTM) Total revenue divided by shares outstanding (may be estimated).
- SEK 18.55
- EPS (TTM) Earnings per share over the last twelve months (may be estimated from net income ÷ shares).
- 2.76
- Shares Outstanding
- 51.03M
- Float Shares
- 43.49M
- Implied Shares Outstanding
- 51.80M
- Operating Margin (TTM) Strong Operating income ÷ revenue over the last twelve months (reconciled when possible).
-
20.12%
- EBITDA Margin (TTM) Reconciled EBITDA ÷ revenue over the last twelve months (suppressed if EBITDA implausible/financials).
-
20.72%
- Gross Margin (TTM) Reconciled Strong Gross profit ÷ revenue over the last twelve months (reconciled when possible).
-
68.37%
- Profit Margin (TTM) Solid Net income ÷ revenue over the last twelve months (reconciled when possible).
-
14.91%
- ROA Return on assets: net income ÷ total assets.
-
2.14%
- ROE Return on equity: net income ÷ shareholder equity.
-
3.11%
- Revenue Growth Strong Year-over-year revenue growth.
-
33.20%
- Earnings Growth (YoY) Strong Year-over-year earnings growth.
-
39.40%
- Earnings Growth (QoQ) Quarter-over-quarter earnings growth.
-
39.70%
- Quick Ratio Adequate Liquid current assets ÷ current liabilities (ex-inventory).
- 2.87
- Debt to Equity Total debt ÷ shareholder equity; leverage.
- 0.04
- Total Cash Cash and equivalents.
- SEK 612.89M
- Total Debt Short + long-term interest-bearing debt.
- SEK 1.64M
- Net Debt Net Cash Total debt − cash (negative = net cash).
- SEK -611.25M
- Debt / EBITDA Leverage relative to operating earnings; lower is safer.
- 0.01
- Operating Cash Flow (TTM) Cash generated by core operations (pre-capex).
- SEK 103.78M
- Free Cash Flow (TTM) Cash after capex; funds buybacks, dividends, and debt paydown.
- SEK 44.31M
- OCF Margin (TTM) Operating cash flow ÷ revenue (TTM).
-
10.96%
- FCF Margin (TTM) Free cash flow ÷ revenue (TTM).
-
4.68%
- Cash Conversion (OpCF/EBITDA)
- 0.53
- Margins shown on a TTM basis. “Reconciled” = numerator ÷ TTM revenue for internal consistency.
- Cash Flow section is displayed only when figures are self-consistent (and hidden for financials).
Disclaimer: Information is compiled from publicly available sources and is subject to errors and omissions. It is provided as a guide only and does not constitute investment advice. Please do your own research.